Medicare Part D is an optional program to help people enrolled in the federal health program pay for prescription drugs. With annual expenses running to about $100 billion last year, it is the dominant insurer in the U.S. pharmaceutical market.
Several studies published in recent years have examined the scope of telemedicine use within the addiction treatment field as well as outcomes related to specific telemedicine interventions and patient groups.
As journalists work to keep communities informed about COVID-19 vaccines, they need to consider questions about safety, distribution and adoption. We address three specific questions, focusing on policies and processes in the U.S.